Clinical Trial Update: Treatment of Brain Metastases From Breast Cancer With Eribulin Mesylate [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating eribulin mesylate for brain metastases from metastatic breast cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer

Drugs mentioned

• ERIBULIN MESYLATE (Eribulin mesylate)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Metastatic Breast Cancer, Brain Metastases | Phase 2 | Status: COMPLETED | Results posted: 2020-03-03